Literature DB >> 1537279

Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells.

J Simard1, Y de Launoit, D E Haagensen, F Labrie.   

Abstract

Recent elucidation of the amino acid sequence of the progesterone-binding protein GCDFP-24, the major protein found in human breast gross cystic disease fluid, reveals that this glycoprotein corresponds to apolipoprotein-D (apo-D), a member of the alpha 2-microglobulin superfamily which binds small hydrophobic ligands. The present study describes the multiple hormonal control of apo-D mRNA levels, intracellular protein content, as well as secretion compared to cell proliferation in human ZR-75-1 breast cancer cells. In these cells, exposure to the synthetic glucocorticoid dexamethasone (DEX) markedly decreases basal as well as 17 beta-estradiol (E2)-induced cell proliferation while causing a maximal 10-fold stimulation of apo-D secretion in the presence or absence of E2. Incubation with 500 nM DEX or 10 nM dihydrotestosterone (DHT), alone and in combination, markedly increased apo-D mRNA/actin mRNA ratios by 16-, 22-, and 28-fold, respectively. Exposure to 1 nM E2 decreased the apo-D mRNA/actin mRNA ratio by 65%. In E2-treated cells, simultaneous exposure to DHT, DEX, and DHT plus DEX markedly increased the apo-D mRNA/actin mRNA ratios by 50-, 35-, and 105-fold, respectively. The stimulatory effect of DEX on intracellular apo-D content and secretion was also additive to that of the androgen DHT in the presence or absence of E2. The present study provides the first data describing the hormonal regulation of apo-D mRNA levels and intracellular protein content and demonstrates the effect of glucocorticoids alone as well as their interaction with androgens and estrogens on these parameters as well as on apo-D secretion. As shown in the present data, the effects of steroids on apo-D gene expression, intracellular apo-D protein content, and secretion are opposite their respective specific effects on cell proliferation in human ZR-75-1 breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537279     DOI: 10.1210/endo.130.3.1537279

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

1.  Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatment.

Authors:  Cristina Pérez; Ana Navarro; Eva Martínez; Cristina Ordóñez; Eva Del Valle; Jorge Tolivia
Journal:  Age (Dordr)       Date:  2011-07-15

Review 2.  Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses.

Authors:  J A Da Silva
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

3.  A strong association between body fat mass and protein profiles in nipple aspirate fluid of healthy premenopausal non-lactating women.

Authors:  Yafei Huang; Manubai Nagamani; Karl E Anderson; Alexander Kurosky; Anthony M Haag; James J Grady; Lee-Jane W Lu
Journal:  Breast Cancer Res Treat       Date:  2006-09-27       Impact factor: 4.872

4.  Increased JNK1 activity contributes to the upregulation of ApoD in the apocrine secretory gland cells from axillary osmidrosis.

Authors:  Hui Chen; Yingli Li; Jie Du; Yan Cao; Xiaoli Li
Journal:  Mol Cell Biochem       Date:  2011-04-28       Impact factor: 3.396

5.  Identification of a gene expression signature for survival prediction in type I endometrial carcinoma.

Authors:  Kristina Levan; Karolina Partheen; Lovisa Osterberg; Björn Olsson; Ulla Delle; Saskia Eklind; György Horvath
Journal:  Gene Expr       Date:  2010

6.  Glucocorticoids and androgens up-regulate the Zn-alpha 2-glycoprotein messenger RNA in human breast cancer cells.

Authors:  Y S López-Boado; I Díez-Itza; J Tolivia; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Liver expression of steroid hormones and Apolipoprotein D receptors in hepatocellular carcinoma.

Authors:  F J Vizoso; M Rodriguez; A Altadill; M L González-Diéguez; A Linares; L O González; S Junquera; F Fresno-Forcelledo; M D Corte; L Rodrigo
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

8.  Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer.

Authors:  R E Hall; J O Aspinall; D J Horsfall; S N Birrell; J M Bentel; R L Sutherland; W D Tilley
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

9.  Increase in placental apolipoprotein D as an adaptation to human gestational diabetes.

Authors:  A Navarro; A Alonso; P Garrido; C González; C González Del Rey; C Ordoñez; J Tolivia
Journal:  Placenta       Date:  2009-11-26       Impact factor: 3.481

10.  Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice.

Authors:  Corine Martineau; Ouafa Najyb; Céline Signor; Éric Rassart; Robert Moreau
Journal:  Metabolism       Date:  2016-05-19       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.